Home
Live Updates
SCYNEXIS : 10-K Filing | MarketScreener : comparemela.com
SCYNEXIS : 10-K Filing | MarketScreener
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
... | March 31, 2023
Related Keywords
State Of New Jersey ,
New Jersey ,
United States ,
Delaware ,
Hong Kong ,
United Kingdom ,
Turkey ,
Taiwan ,
Massachusetts ,
China ,
California ,
Australia ,
Russia ,
Virginia ,
Colorado ,
Macau ,
Japan ,
Connecticut ,
Ukraine ,
Nevada ,
Washington ,
Sydney ,
New South Wales ,
South Africa ,
Canada ,
Russian ,
Canadian ,
America ,
Russian Federation ,
American ,
David Hastings ,
Brian Philippe Tinmouth ,
Marco Taglietti ,
Azoles Noxafil ,
Stevenc Gilman ,
Christine Coyne ,
Histoplasmaandblastomycesgenera Candidaandaspergillusgenera ,
Armando Anido ,
Annf Hanham ,
Evertrust Plaza ,
Scott Sukenick ,
David Angulo ,
Ivor Macleod ,
Guggenheim Securities ,
Medicaid Services ,
Us Department Of Justice ,
Us Supreme Court ,
European Union ,
Amplyx Pharmaceuticals Inc ,
Puissance Life Science Opportunities Fund Vi ,
Athersys Inc ,
Officers Of The Company ,
Data Review Committee ,
Corporate Governance Committee ,
European Union Withdrawal ,
Development Accruals ,
Mycovia Pharmaceuticals Inc ,
Healthcare Regulatory Agency ,
Name Of Each Exchange On Which ,
Centers For Medicare ,
Jersey Technology Business Tax Certificate Transfer ,
Public Company Accounting Oversight Board United States ,
Ladenburg Thalmann Co ,
Centers For Disease Control ,
Merck Co Inc ,
Exchange Commission ,
Hercules Capital Inc ,
Pacific Pty Ltd ,
United States Court ,
Centers For Medicare Medicaid Services ,
European Medicines Agency ,
National Institutes Of Health ,
Cantor Fitzgerald Co ,
Health Care ,
Waterstone Pharmaceutical Hk Limited Or ,
Jersey Economic Development Authority ,
United Cypralis Limited Or ,
Health Information Technology For Economic ,
Scynexis Inc ,
Children Health Insurance Program ,
Biden Administration ,
Iv Ibrexafungerp Development Program ,
Merck Sharp Dohme Corp ,
Corporation Law ,
World Health Organization ,
Silicon Valley Bank ,
Amplity Health ,
Clinical Health ,
Trademark Office ,
Key Development Milestones ,
Human Services ,
Office Of Inspector ,
Nasdaq ,
While The Company ,
Federal Reserve ,
Commission File Number ,
Us Department Of Health ,
Pfizer ,
Supreme Court ,
Health Insurance Portability ,
Department Of Justice ,
Waterstone ,
Centers For Disease ,
Silicon Valley Bank The Loan Agreement ,
Cidara Therapeutics Inc ,
Case Western Reserve University ,
California Department Of Financial Protection ,
Clinical Development Arrangements ,
Jiangsu Hansoh Pharmaceutical Group Company ,
Securities Exchange ,
Matinas Biopharma Holdings Inc ,
Exchange Act Rule ,
Development Expense ,
Community Clinical Programs ,
Our Core Drug Development Operations ,
Government Accountability Office ,
Drug Administration ,
Company On ,
Hansoh Shanghai Health Technology Co Ltd ,
Deposit Insurance Corporation ,
California Privacy Protection Agency ,
Mark One ,
Zip Code ,
Each Exchange ,
Securities Exchange Act ,
Interactive Data File ,
Regulations T ,
Sarbanes Oxley Act ,
Exchange Act ,
Common Stock ,
Nasdaq Global Market ,
Annual Report ,
Securities Act ,
Financial Condition ,
License Agreement ,
Regulatory Approval ,
Product Candidates For Human ,
Employee Matters ,
Risks Relating ,
Glaxosmithkline Intellectual Property ,
Greater China ,
Hart Scott Rodino Antitrust Improvements Act ,
Licensing Agreements Associated ,
Core Drug Development Operations ,
Hercules Capital ,
Silicon Valley Bridge Bank ,
Security Agreement ,
Loan Agreement ,
First Amendment ,
Qualified Infectious Disease Product ,
Fast Track ,
Orphan Drug ,
Orphan Medicinal Product ,
Innovation Passport ,
Generating Antibiotic Incentives Now ,
Community Clinical ,
Invasive Fungal Infections ,
Disease Control ,
Antibiotic Resistance Threats ,
Century Cures Act ,
National Institutes ,
Mycovia Pharmaceuticals ,
Cidara Therapeutics ,
Melinta Therapeutics ,
Core Drug Development ,
Merck Sharp ,
Deferred Milestone ,
Exclusive License ,
Collaboration Agreement ,
Central Asian ,
Middle Eastern ,
North African ,
Federal Food ,
Cosmetic Act ,
Post Marketing Requirements ,
Prescription Drug Marketing Act ,
Federal Trade Commission Act ,
California Consumer Privacy Act ,
Canadian Personal Information Protection ,
Electronic Documents Act ,
Anti Spam Legislation ,
General Data Protection Regulation ,
Payment Card Industry Data Security Standard ,
Consumer Data Protection Act ,
Colorado Privacy ,
California Privacy Rights Act ,
Inspector General ,
Anti Kickback Statute ,
Patient Protection ,
Affordable Care Act ,
Education Reconciliation Act ,
False Claims Act ,
Federal Health Insurance Portability ,
Accountability Act ,
Physician Payments Sunshine Act ,
Health Insurance Program ,
Health Information Technology ,
Clinical Health Act ,
Affordable Care ,
President Biden ,
Inflation Reduction Act ,
Infrastructure Investment ,
Jobs Act ,
American Taxpayer Relief Act ,
American Economy ,
Comprehensive Plan ,
Addressing High Drug Prices ,
Medicaid Innovation ,
Drug Price Competition ,
Patent Term Restoration Act ,
Hatch Waxman Act ,
Factors Risks Relating ,
Intellectual Property ,
Jersey City ,
Puissance Life Science Opportunities Fund ,
California Department ,
Financial Protection ,
Risk Evaluation ,
Mitigation Strategy ,
Generating Antibiotic Incentives Now Act ,
Tax Cuts ,
Good Manufacturing Practices ,
False Claims ,
Federal Circuit ,
Data Protection Regulation ,
European Economic Area ,
Owning Our Common ,
Delaware General Corporation Law ,
Silicon Valley ,
Equity Securities ,
Note Regarding Forward Looking ,
Chief Executive Officer ,
Chief Medical Officer ,
Chief Financial Officer ,
Chief Commercial Officer ,
Cantor Fitzgerald ,
Ladenburg Thalmann ,
Aspire Capital ,
Years Ended December ,
Ended December ,
Product Revenues For ,
Development For ,
Debt Issuance Costs ,
Cdiscount For ,
Income For ,
Expense For ,
Liabilities Fair Value ,
Liabilities Fair Value Adjustment For ,
Tax Benefit For ,
New Jersey Net Operating Losses ,
Cash Needs ,
Accounting Judgments ,
Accounting Standards Codification ,
Patient Assistance Programs ,
Trade Discounts ,
Collaborative Arrangements ,
Fair Value ,
Stock Based Compensation ,
Accounting Bulletin ,
Public Company Accounting Oversight Board ,
Significant Accounting ,
Accounting Standards Codification Topic ,
Critical Audit Matter Was Addressed ,
Going Concern ,
Term Loan ,
Federal Deposit Insurance Corporation ,
Wholesaler Fees ,
Stocking Fees ,
Convertible Senior Notes ,
Diluted Net Loss ,
Earnings Per ,
Earnings Per Share ,
Chief Executive ,
Pty Ltd ,
Prior Year ,
Financial Instruments Credit Losses ,
Financial Instruments ,
Own Equity ,
Convertible Instruments ,
First Performance Milestone ,
Maturity Date ,
Prime Rate ,
Wall Street Journal ,
Senior Convertible Note Purchase Agreement ,
Purchase Agreement ,
Deferred Fees ,
Please The ,
Potential Future ,
Dohme Corp ,
Outstanding Common ,
Restated Certificate ,
Stock Purchase Agreement ,
Common Stock Purchase Agreement ,
Stock Purchase ,
Common Stock Purchase ,
Controlled Equity ,
Equity Underwriting Agreement ,
Distinguishing Liabilities ,
Danforth Advisors ,
United Kingdom Based Cypralis Limited ,
Waterstone Pharmaceutical ,
New Jersey Economic Development Authority ,
Internal Revenue Code ,
Income Taxes ,
Incentive Plan ,
Effective Date ,
Option Plan ,
Stock Purchase Plan ,
Internal Revenue ,
Liabilities Measured ,
Identical Assets ,
Unobservable Inputs ,
Disclosure Controls ,
Internal Control ,
Internal Control Integrated Framework ,
Sponsoring Organizations ,
Internal Control Over Financial ,
Proxy Statement ,
Its Committees ,
Section Reports ,
Business Conduct ,
Certain Beneficial Owners ,
Compensation Plan Information ,
Accountant Fees ,
Financial Statements ,
Financial Statement ,
Principal Executive Officer ,
Principal Financial ,
Accounting Officer ,
Brian Philippe ,
Scynexis ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
United ,
Securities ,
End ,
Exchange ,
Orm Scyx Us8112922005 ,
comparemela.com © 2020. All Rights Reserved.